Evidence map›Paper›PMID 39205210›Full record

ArticleViruses2024

The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study.

Ijeoma M Ifeorah, Athenais Gerber, Samira Dziri, Solomon A Bakarey, Frederic Le Gal, Gatuwa Aglavdawa, Chakib Alloui, Stephen O Kalu, Peyou-Amed B Ghapouen, Segolene Brichler and 2 more

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Hepatitis Delta and Liver Disease Among People Living With Hepatitis B With or Without HIV Co-Infection in Senegal.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ijeoma M IfeorahDepartment of Medical Laboratory Science, Faculty of Health Sciences and Technology, University of Nigeria Enugu Campus, Enugu 200241, Nigeria.ORCID 0000-0003-0911-7179
Athenais GerberCentre National de Référence des Hépatites B, C et Delta, Laboratoire de Microbiologie Clinique, Hôpital-Avicenne, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Cité, 93000 Bobigny, France.
Samira DziriCentre National de Référence des Hépatites B, C et Delta, Laboratoire de Microbiologie Clinique, Hôpital-Avicenne, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Cité, 93000 Bobigny, France.ORCID 0000-0002-8110-886X
Solomon A BakareyInstitute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan 200212, Nigeria.ORCID 0000-0001-6735-1874
Frederic Le GalCentre National de Référence des Hépatites B, C et Delta, Laboratoire de Microbiologie Clinique, Hôpital-Avicenne, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Cité, 93000 Bobigny, France.
Gatuwa AglavdawaDepartment of Hematology and Blood Transfusion, Federal Teaching Hospital Gombe, Gombe 620261, Nigeria.
Chakib AllouiCentre National de Référence des Hépatites B, C et Delta, Laboratoire de Microbiologie Clinique, Hôpital-Avicenne, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Cité, 93000 Bobigny, France.
Stephen O KaluMedical Microbiology and Parasitology Department, Nnamdi Azikiwe University Teaching Hospital Nnewi, Nnewi 431101, Nigeria.
Peyou-Amed B GhapouenDepartment of Medical Laboratory Sciences, Taraba State University Jalingo, Jalingo 930283, Nigeria.
Segolene BrichlerCentre National de Référence des Hépatites B, C et Delta, Laboratoire de Microbiologie Clinique, Hôpital-Avicenne, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Cité, 93000 Bobigny, France.
Olubusuyi M AdewumiDepartment of Virology, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Ibadan 200212, Nigeria.ORCID 0000-0002-5172-5808
Emmanuel GordienCentre National de Référence des Hépatites B, C et Delta, Laboratoire de Microbiologie Clinique, Hôpital-Avicenne, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Cité, 93000 Bobigny, France.ORCID 0000-0003-2664-9417

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis delta virus (HDV) is a satellite of hepatitis B virus (HBV), which requires the HBV surface antigen (HBsAg) for its assembly and propagation. Although countries affected by HBV infection in Africa are well identified, data on HDV infection are still scarce, like in Nigeria, where HBV infection is endemic. In this study, we aimed to determine the prevalence of HDV infection and identify the circulating genotypes/strains in the country. A nationwide study was performed on 1281 HBsAg-positive samples collected from patients across eleven sites drawn from the six geopolitical zones in Nigeria. Anti-HDV antibody (HDV-Ab) screening and HDV-RNA viral load quantification were performed using a commercial ELISA assay and real-time RT-PCR kit, respectively. HDV genotyping was performed by the Sanger sequencing of amplicons from the so-called

Indexed as

GenotypeHepatitis DHepatitis Delta VirusMolecular EpidemiologyPhylogenyAdolescentAdultAgedChildFemaleHepatitis AntibodiesHepatitis BHepatitis B Surface AntigensHumansMaleMiddle AgedHepatitis AntibodiesHepatitis B Surface AntigensRNA, ViralgenotypeHDVnationwide studyNigeria

Identifiers

PMID39205210
PMCPMC11359409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.